Oncolytics Biotech Inc.ONCYNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank5
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P5
Near historical low
vs 5Y Ago
-115.8x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -133.58% |
| Q2 2025 | 7.81% |
| Q1 2025 | 16.59% |
| Q4 2024 | 15.99% |
| Q3 2024 | -79.95% |
| Q2 2024 | 23.08% |
| Q1 2024 | -74.58% |
| Q4 2023 | 46.63% |
| Q3 2023 | -33.56% |
| Q2 2023 | -16.41% |
| Q1 2023 | 24.47% |
| Q4 2022 | -86.73% |
| Q3 2022 | 15.43% |
| Q2 2022 | 25.44% |
| Q1 2022 | 12.96% |
| Q4 2021 | -59.03% |
| Q3 2021 | 34.48% |
| Q2 2021 | -16.14% |
| Q1 2021 | 45.53% |
| Q4 2020 | -38.23% |
| Q3 2020 | 1.15% |
| Q2 2020 | -1808.30% |
| Q1 2020 | 102.06% |
| Q4 2019 | -449.83% |
| Q3 2019 | 32.84% |
| Q2 2019 | -6.38% |
| Q1 2019 | -2.48% |
| Q4 2018 | -44.47% |
| Q3 2018 | 20.79% |
| Q2 2018 | 9.83% |
| Q1 2018 | 1.58% |
| Q4 2017 | -57.95% |
| Q3 2017 | 30.92% |
| Q2 2017 | -23.64% |
| Q1 2017 | 32.48% |
| Q4 2016 | -56.34% |
| Q3 2016 | -29.13% |
| Q2 2016 | 35.75% |
| Q1 2016 | -14.87% |
| Q4 2015 | -23.83% |